Unknown OBSERVATIONAL NCT01816022

Myeloproliferative Neoplasms and Bone Structure

Sponsor: University of Southern Denmark

Conditions Polycythemia Vera Primary Myelofibrosis Thrombocythemia, Essential

Updated 10 times since 2017 Last updated: Mar 20, 2013 Started: Mar 31, 2012 Primary completion: Mar 31, 2014 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01816022, this observational or N/A phase trial focuses on Polycythemia Vera and Primary Myelofibrosis and remains ongoing. Sponsored by University of Southern Denmark, it has been updated 10 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Unknown Status NA
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Southern Denmark

Data source: University of Southern Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Odense, Denmark